Dr. Anne de Brugerolle
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Anne de Brugerolle
- Current 12 years and 2 months, since Apr 2014
Business Unit Development Manager Healthcare & Innovation
Independent
- Strategic analysis to leverage the added-value of partnerships in early development (in&out licensing, co-development) - Optimization of the empowerment of the center of excellence - Team Management in a competitive environment & changes
- 1 year and 4 months, Oct 2015 - Jan 2017
Business Development Healthcare
IDF INNOV
Strategic valorisation and partnership network of the academic innovation in Healthcare Analysis and management of the valorization of licensing out, industrial properties and negotiation of the Healthcare portfolio Marketing and commercial offers
- 9 months, Jul 2013 - Mar 2014
Business Development International Market Access
Sanofi Pasteur
- Market access for Greater Europe, Russia (3rd market) and Brazil (2nd market) - Pediatric and influenza vaccines - Identification of local partners - Strategic analysis to enter into local public markets - Communication of Business and Development plans to the corporate management
- 5 years and 6 months, Sep 2006 - Feb 2012
Business Unit Manager
L'OREAL
- Research, production & commercialization of human in vitro bioengineered human tissues - Annual sales 2006-10 X2 at 3 Mn€, with an equal headcount of 15 FTEs in a niche market - BtoB with 140 partners in Big Pharma, Cosmetics, CROs, Chemical industry & Academics - European validation of two epidermal in vitro models for acute skin irritation - Implementation of distribution networks in Japan and USA - Implementation & management of QA, EHS and certification ISO9001
- 6 years and 9 months, Jan 2000 - Sep 2006
Head of Alliance Management, Translational Medicine
Novartis Pharma AG
- Alliance management of industrial and academic partnerships in EU (preclinical and clinical CROs), USA (Organogenesis, biotechnologies), Asia (Clinical CROs in India) - Market access of innovative products, mainly, in Immunology: Neoral, Sandimmun, Certican, in Asthma: Xolair (anti-IgE) and in Dermatology: Lamisil, Elidel, Apligraf (artificial skin) - Communication plans to the Healthcare Authorities (FDA on tiered strategy on “omics” based biomarkers)
- 7 years, Jan 1993 - Dec 1999
Senior Toxicologist, Research & Development
Novartis Pharma AG
- Management of technological platforms in Immunotoxicology (local tolerance and contact (photo) allergy) and Drug Delivery Systems (dermatological, transdermal, subcutaneous, nasal and pulmonary formulations) under GLP conditions - Development of preclinical programs to support the launch of products in Immunology (Sandostatin, Neoral, Sandimmun, Certican), in Asthma (Xolair) and in Dermatology (Elidel, Lamisil, Apligraf)
Ausbildung von Anne de Brugerolle
- 4 months, Sep 2000 - Dec 2000
Fontainebleau
INSEAD
- 1 year and 10 months, Sep 1987 - Jun 1989
Biologie Humaine
Université Claude Bernard Lyon I
Immunologie Dermatologie
- 7 years and 10 months, Sep 1979 - Jun 1987
Pharmacie
Université Claude Bernard Lyon I
Sprachen
French
C2 (Verhandlungssicher / Muttersprachlich)
English
C1 (Fließend)
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
21 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.